黑龙江黑河市:禁止网络销售、购买“退烧止咳抗病毒”药品

2021-01-09 黑河市场监管局 黑河市场监管局

禁止网络销售、购买

禁止网络销售、购买

“退烧止咳抗病毒”药品的通告

爱辉区药品经营企业及广大市民:

为保障人民群众身体健康,有效控制和降低疫情传播风险,切实落靠药店疫情防控“哨点”责任,最大发挥使用“沃填报”系统实名销售“退烧止咳抗病毒”类药品监测作用,黑河市市场监督管理局在疫情防控期间禁止药品经营企业网络销售“退烧止咳抗病毒”类药品、禁止市民在网络购买“退烧止咳抗病毒”类药品。

广大市民如需购买“退烧止咳抗病毒”类药品,应持有本人身份证原件,到药店使用“沃填报”系统报告购药人姓名、身份证号码、手机号码、药品名称、数量、销售企业等信息后方可购买。如有发热、咳嗽等疑似症状人员,请及时到发热门诊就诊用药。

特此通告

黑河市市场监督管理局

2020年1月8日

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1908026, encodeId=a71e1908026c5, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Wed Nov 17 02:32:05 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687385, encodeId=9eb6168e385b4, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Thu Oct 14 09:32:05 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046613, encodeId=4ea8204661361, content=<a href='/topic/show?id=9835e95272f' target=_blank style='color:#2F92EE;'>#网络销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79527, encryptionId=9835e95272f, topicName=网络销售)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Mon Aug 02 15:32:05 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292540, encodeId=314812925408d, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55471, encryptionId=a3b4554e19d, topicName=抗病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Jan 11 14:32:05 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915218, encodeId=71db915218a6, content=订阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Jan 10 14:37:26 CST 2021, time=2021-01-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1908026, encodeId=a71e1908026c5, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Wed Nov 17 02:32:05 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687385, encodeId=9eb6168e385b4, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Thu Oct 14 09:32:05 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046613, encodeId=4ea8204661361, content=<a href='/topic/show?id=9835e95272f' target=_blank style='color:#2F92EE;'>#网络销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79527, encryptionId=9835e95272f, topicName=网络销售)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Mon Aug 02 15:32:05 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292540, encodeId=314812925408d, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55471, encryptionId=a3b4554e19d, topicName=抗病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Jan 11 14:32:05 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915218, encodeId=71db915218a6, content=订阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Jan 10 14:37:26 CST 2021, time=2021-01-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1908026, encodeId=a71e1908026c5, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Wed Nov 17 02:32:05 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687385, encodeId=9eb6168e385b4, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Thu Oct 14 09:32:05 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046613, encodeId=4ea8204661361, content=<a href='/topic/show?id=9835e95272f' target=_blank style='color:#2F92EE;'>#网络销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79527, encryptionId=9835e95272f, topicName=网络销售)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Mon Aug 02 15:32:05 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292540, encodeId=314812925408d, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55471, encryptionId=a3b4554e19d, topicName=抗病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Jan 11 14:32:05 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915218, encodeId=71db915218a6, content=订阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Jan 10 14:37:26 CST 2021, time=2021-01-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1908026, encodeId=a71e1908026c5, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Wed Nov 17 02:32:05 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687385, encodeId=9eb6168e385b4, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Thu Oct 14 09:32:05 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046613, encodeId=4ea8204661361, content=<a href='/topic/show?id=9835e95272f' target=_blank style='color:#2F92EE;'>#网络销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79527, encryptionId=9835e95272f, topicName=网络销售)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Mon Aug 02 15:32:05 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292540, encodeId=314812925408d, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55471, encryptionId=a3b4554e19d, topicName=抗病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Jan 11 14:32:05 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915218, encodeId=71db915218a6, content=订阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Jan 10 14:37:26 CST 2021, time=2021-01-10, status=1, ipAttribution=)]
    2021-01-11 yahu
  5. [GetPortalCommentsPageByObjectIdResponse(id=1908026, encodeId=a71e1908026c5, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Wed Nov 17 02:32:05 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687385, encodeId=9eb6168e385b4, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Thu Oct 14 09:32:05 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046613, encodeId=4ea8204661361, content=<a href='/topic/show?id=9835e95272f' target=_blank style='color:#2F92EE;'>#网络销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79527, encryptionId=9835e95272f, topicName=网络销售)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Mon Aug 02 15:32:05 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292540, encodeId=314812925408d, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55471, encryptionId=a3b4554e19d, topicName=抗病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Jan 11 14:32:05 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915218, encodeId=71db915218a6, content=订阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Jan 10 14:37:26 CST 2021, time=2021-01-10, status=1, ipAttribution=)]
    2021-01-10 zb1235672

    订阅

    0

相关资讯

医保新规今日实施:八类药品不纳入基本医保

今日(9月1日),国家医保局曾于7月31日公布《基本医疗保险用药管理暂行办法》(以下简称暂行办法)正式实施。

详解医保目录调整 调入药品不仅“物美”还应“价廉”

医保目录调整大幕拉开,谁走谁留,规则终于敲定。

武田完成向Cheplapharm出售部分非核心资产

武田药品工业株式会社今天宣布完成其先前宣布的向Cheplapharm出售部分处方药品阵容的交易,交易总价值为5.62亿美元。

两类情况药品临床期间即可申请批准!《药品附条件批准上市技术指导原则(试行)》即日实施

昨日(11月19日),国家药监局CDE发布关于《药品附条件批准上市技术指导原则(试行)》(以下简称指导原则)的通告,根据通告,《指导原则》自发布之日起正式施行。

喜讯!国家采购“以量换价” 55种药品降价了!

第三批国家带量采购本月执行,55种药品、191个产品中选,涉及高血压、糖尿病、恶性肿瘤等药品品种,平均降价53%!以化疗用药卡培他滨为例,药品由原来的每片15元降至3元多。国家集采怎样通过&ldquo

“一支药70万元”“国外便宜国内贵”?聚焦“天价”罕见病药

日前,网络流传“治疗罕见病‘脊髓性肌萎缩症’特效药物需‘70万元一支’天价,且国内价格远高于国外”,引发社会关注。